---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-011472"
form_type: "8-K"
ticker: "OVID"
cik: "0001636651"
company_name: "Ovid Therapeutics Inc."
filed_at: "2022-06-10T23:59:59+00:00"
generated_at: "2026-06-25T02:46:33.187040+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Ovid Therapeutics annual meeting elects two directors, ratifies KPMG

## Summary
- Annual meeting held June 9, 2022; 58.53% quorum (41,220,715 of 70,417,345 shares).
- Kevin Fitzgerald elected: 23,339,939 for, 76,303 withheld; broker non-votes 17,804,473.
- Bart Friedman elected: 17,204,205 for, 6,212,037 withheld; broker non-votes 17,804,473.
- Ratification of KPMG as auditor for FY2022: 40,049,679 for, 1,157,936 against, 13,100 abstain.

## SEC filing metadata
- accession: 0000950170-22-011472
- form_type: 8-K
- ticker: OVID
- cik: 0001636651
- company_name: Ovid Therapeutics Inc.
- filed_at: 2022-06-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1636651/000095017022011472/0000950170-22-011472-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1636651/000095017022011472/ovid-20220609.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-011472
- JSON: https://secwatch.observer/filing/0000950170-22-011472.json
- Plain text: https://secwatch.observer/filing/0000950170-22-011472.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.